TD Cowen analyst Daniel Brennan maintained a Buy rating on GeneDx Holdings (WGS – Research Report) today and set a price target of $118.00. The ...

TD Cowen raised the firm’s price target on Fiserv (FI) to $277 from $235 and keeps a Buy rating on the shares. The firm said the quarter ...

As Eli Lilly ends the year with Zepbound in good supply, TD Cowen analyst Steve Scaliaasked CEO David Ricks if the company ...

TD Cowen's analysts adjusted their expectations for Skyworks Solutions (NASDAQ:SWKS), reducing the price target from $90.00 to $75.00 while maintaining a Hold rating on the stock. According to ...

TD Cowen reinstated coverage on Tempus AI with a "Buy" rating and raised its price target to $74 after the health-tech ...

OSI Systems, Inc. (NASDAQ: OSIS), today announced that it will present at the TD Cowen 46th Annual Aerospace & Defense Conference on Wednesday, February 12, 2025, at 10:45 AM ET.

The transportation sector will be impacted by Trump's new tariff regime. Parcel consolidators and freight forwarders - like ...

Johnson & Johnson (NYSE: JNJ) will present at the 45th Annual TD Cowen Healthcare Conference on Tuesday, March 4th, 2025. Management will participate in a fireside chat at 11:10 a.m. Eastern Time.

TD Cowen expressed concerns about valuation. “If Celsius can’t demonstrate a path back to growth, it could end up being valued at a multiple more similar to other ex-growth CPG companies,” the note ...

TD Cowen initiated coverage of KalVista (KALV) with a Buy rating and $30 price target The firm cites sebetralstat’s opportunity as the first oral acute therapy for hereditary angioedema attacks ...